Growth Metrics

Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026)

Axsome Therapeutics recorded quarterly Current Taxes of $99000.0 in Q1 2026, down 1.98% quarter-over-quarter from $101000.0 in Q4 2025, and down 89.69% year-over-year from $960000.0 in Q1 2025.

Axsome Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $99000.0 for Q1 2026.

  • In Q1 2026, Current Taxes fell 89.69% year-over-year to $99000.0; the TTM figure through Mar 2026 stood at $99000.0 (down 89.69% YoY), while the FY2025 annual figure was $101000.0, down 89.48% from the prior year.
  • Current Taxes came in at $99000.0 for Q1 2026 at Axsome Therapeutics, down from $101000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $960000.0 in Q4 2024 to a low of $99000.0 in Q1 2026.
  • A 3-year average of $514000.0 and a median of $493000.0 in 2024 frame the typical range for Current Taxes.
  • Across the five-year window, Current Taxes soared 95.12% in 2025 and tumbled 89.69% in 2026, its largest moves.
  • Axsome Therapeutics' Current Taxes stood at $960000.0 in 2024, then tumbled by 89.48% to $101000.0 in 2025, then decreased by 1.98% to $99000.0 in 2026.
  • According to Business Quant data, Current Taxes over the past three periods registered $99000.0, $101000.0, and $960000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 10,460.56
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 19.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Axsome Therapeutics 11.82 Bn 11.51 Bn 176.48 Mn 99,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 99,000.00
Dec 31, 2025 101,000.00
Mar 31, 2025 960,000.00
Dec 31, 2024 960,000.00
Sep 30, 2024 493,000.00
Jun 30, 2024 493,000.00
Mar 31, 2024 492,000.00